Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop

2018 ◽  
Vol 21 (3-4) ◽  
pp. 121-132 ◽  
Author(s):  
Christos Nikolaidis ◽  
Chang Ming ◽  
Carla Pedrazzani ◽  
Tina van der Horst ◽  
Andrea Kaiser-Grolimund ◽  
...  
Cancers ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 925
Author(s):  
Vasiliki Baroutsou ◽  
Meghan L. Underhill-Blazey ◽  
Christian Appenzeller-Herzog ◽  
Maria C. Katapodi

Evidence-based guidelines recommend cascade genetic testing of blood relatives of known Hereditary Breast and Ovarian Cancer (HBOC) or Lynch Syndrome (LS) cases, to inform individualized cancer screening and prevention plans. The study identified interventions designed to facilitate family communication of genetic testing results and/or cancer predisposition cascade genetic testing for HBOC and LS. We conducted a systematic review and meta-analysis of randomized trials that assessed intervention efficacy for these two outcomes. Additional outcomes were also recorded and synthesized when possible. Fourteen articles met the inclusion criteria and were included in the narrative synthesis and 13 in the meta-analysis. Lack of participant blinding was the most common risk of bias. Interventions targeted HBOC (n = 5); both HBOC and LS (n = 4); LS (n = 3); or ovarian cancer (n = 2). All protocols (n = 14) included a psychoeducational and/or counseling component. Additional components were decision aids (n = 4), building communication skills (n = 4), or motivational interviewing (n = 1). The overall effect size for family communication was small (g = 0.085) and not significant (p = 0.344), while for cascade testing, it was small (g = 0.169) but significant (p = 0.014). Interventions show promise for improving cancer predisposition cascade genetic testing for HBOC and LS. Future studies should employ family-based approaches and include racially diverse samples.


2018 ◽  
Vol 10 (9) ◽  
Author(s):  
Salha Bujassoum ◽  
Reem Alsulaiman ◽  
Hind Elmalik ◽  
Kulssom Junejo ◽  
Ahmed Mahfouz ◽  
...  

2020 ◽  
pp. 1-5
Author(s):  
Sheila Unger ◽  
Eléonore Simond ◽  
Emeline Davoine ◽  
Maria C. Katapodi ◽  
Sheila Unger

In Switzerland, out of respect for privacy and in accordance with federal laws regarding genetic testing, information sharing about hereditary cancer predisposition syndromes is initiated solely by the proband and never from the medical clinic. Thus, an essentially medical task, communication of cancer risk and possible testing, is always delegated, at least initially, to the patient. In order to explore this communication process, its associated difficulties and possibilities for improvements, we have conducted a study with Lynch syndrome families in Western Switzerland. Semi-structured interviews were conducted with 19 participants (12 female, 7 male), either in person or by telephone. We specifically explored whether participants considered transmission of genetic information a medical or personal responsibility. Other recurrent themes were also identified, including family wisdom and superstitions, emotional responses, and parent-child guilt. The identification of a cancer predisposition and the request to communicate this with family members remained a traumatic experience for many. However, within this group, which may be biased towards better communicators, the information was shared with at risk relatives. Despite inherent difficulties, the majority wish to retain the responsibility for contacting family members. This suggests that in Switzerland, and possibly in other countries with similar rules/attitudes towards privacy, efforts to improve cascade screening should be directed towards facilitating intra-familial communication.


Sign in / Sign up

Export Citation Format

Share Document